Jennifer Fitzpatrick's most recent trade in Sionna Therapeutics Inc. was a trade of 10,250 Common Stock done at an average price of $6.1 . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. | 05 Mar 2026 | 10,250 | 10,250 | - | 6.1 | 62,628 | Common Stock |
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 10,250 | 50,935 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 33.86 per share. | 05 Mar 2026 | 10,250 | 0 | - | 33.9 | 347,019 | Common Stock |
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 103,140 | 103,140 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 40.52 per share. | 05 Dec 2025 | 10,250 | 0 | - | 40.5 | 415,330 | Common Stock |
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. | 05 Dec 2025 | 10,250 | 10,250 | - | 6.1 | 62,628 | Common Stock |
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 10,250 | 61,185 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. | 04 Sep 2025 | 10,250 | 10,250 | - | 6.1 | 62,628 | Common Stock |
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 10,250 | 71,435 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sionna Therapeutics Inc | Jennifer Fitzpatrick | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.12 per share. | 04 Sep 2025 | 10,250 | 0 | - | 23.1 | 236,980 | Common Stock |